List of Tables
Table 1. Neurodegenerative Disease Treatment Drug Market Trends
Table 2. Neurodegenerative Disease Treatment Drug Market Drivers & Opportunity
Table 3. Neurodegenerative Disease Treatment Drug Market Challenges
Table 4. Neurodegenerative Disease Treatment Drug Market Restraints
Table 5. Global Neurodegenerative Disease Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Neurodegenerative Disease Treatment Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Neurodegenerative Disease Treatment Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Neurodegenerative Disease Treatment Drug
Table 10. Global Neurodegenerative Disease Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Neurodegenerative Disease Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Neurodegenerative Disease Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Neurodegenerative Disease Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Neurodegenerative Disease Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Neurodegenerative Disease Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Neurodegenerative Disease Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Neurodegenerative Disease Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Neurodegenerative Disease Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Neurodegenerative Disease Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Neurodegenerative Disease Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Neurodegenerative Disease Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Neurodegenerative Disease Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Neurodegenerative Disease Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Neurodegenerative Disease Treatment Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Neurodegenerative Disease Treatment Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Neurodegenerative Disease Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Neurodegenerative Disease Treatment Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Neurodegenerative Disease Treatment Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbvie Inc. Basic Information List
Table 32. Abbvie Inc. Description and Business Overview
Table 33. Abbvie Inc. Neurodegenerative Disease Treatment Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Neurodegenerative Disease Treatment Drug Business of Abbvie Inc. (2019-2024)
Table 35. Abbvie Inc. Recent Developments
Table 36. Amneal Pharmaceuticals Inc. Basic Information List
Table 37. Amneal Pharmaceuticals Inc. Description and Business Overview
Table 38. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Neurodegenerative Disease Treatment Drug Business of Amneal Pharmaceuticals Inc. (2019-2024)
Table 40. Amneal Pharmaceuticals Inc. Recent Developments
Table 41. Boehringer Ingelheim International Gmbh Basic Information List
Table 42. Boehringer Ingelheim International Gmbh Description and Business Overview
Table 43. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Neurodegenerative Disease Treatment Drug Business of Boehringer Ingelheim International Gmbh (2019-2024)
Table 45. Boehringer Ingelheim International Gmbh Recent Developments
Table 46. Hoffmann-La Roche Basic Information List
Table 47. Hoffmann-La Roche Description and Business Overview
Table 48. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Neurodegenerative Disease Treatment Drug Business of Hoffmann-La Roche (2019-2024)
Table 50. Hoffmann-La Roche Recent Developments
Table 51. Merck & Co. Inc. Basic Information List
Table 52. Merck & Co. Inc. Description and Business Overview
Table 53. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Neurodegenerative Disease Treatment Drug Business of Merck & Co. Inc. (2019-2024)
Table 55. Merck & Co. Inc. Recent Developments
Table 56. Key Raw Materials Lists
Table 57. Raw Materials Key Suppliers Lists
Table 58. Neurodegenerative Disease Treatment Drug Downstream Customers
Table 59. Neurodegenerative Disease Treatment Drug Distributors List
Table 60. Research Programs/Design for This Report
Table 61. Key Data Information from Secondary Sources
Table 62. Key Data Information from Primary Sources
Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Neurodegenerative Disease Treatment Drug Product Picture
Figure 2. Global Neurodegenerative Disease Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 5. Global Neurodegenerative Disease Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurodegenerative Disease Treatment Drug Revenue in 2023
Figure 7. Neurodegenerative Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. N-methyl-D-aspartate Receptor antagonists Picture
Figure 9. Cholinesterase Inhibitors Picture
Figure 10. Dopamine Agonists Picture
Figure 11. Immunomodulatory Drugs Picture
Figure 12. Others Picture
Figure 13. Global Neurodegenerative Disease Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Neurodegenerative Disease Treatment Drug Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Others
Figure 18. Global Neurodegenerative Disease Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Neurodegenerative Disease Treatment Drug Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Neurodegenerative Disease Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Neurodegenerative Disease Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Neurodegenerative Disease Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Neurodegenerative Disease Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Neurodegenerative Disease Treatment Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Neurodegenerative Disease Treatment Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Neurodegenerative Disease Treatment Drug Sales Value (%), (2019-2030)
Figure 31. United States Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. China Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. China Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. India Neurodegenerative Disease Treatment Drug Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Neurodegenerative Disease Treatment Drug Sales Value by Type (%), 2023 VS 2030
Figure 51. India Neurodegenerative Disease Treatment Drug Sales Value by Application (%), 2023 VS 2030
Figure 52. Neurodegenerative Disease Treatment Drug Industrial Chain
Figure 53. Neurodegenerative Disease Treatment Drug Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
